Anyone tracking international media over the past few decades will already know Sam Barnett is a power player in the C-suite.
In this video, Matthew S. Davids, MD, said data from the BRUIN-313 trial supports front-line approval of pirtobrutinib in patients with previously untreated chronic lymphocytic leukemia or small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback